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In West Africa, Mycobacterium tuberculosis strains co-
circulate with M. africanum, and both pathogens cause pul-
monary	tuberculosis	in	humans.	Given	recent	findings	that	
M. tuberculosis T-cell epitopes are hyperconserved, we hy-
pothesized that more immunogenic strains have increased 
capacity to spread within the human host population. We 
investigated the relationship between the composition of 
the mycobacterial population in The Gambia, as measured 
by spoligotype analysis, and the immunogenicity of these 
strains	as	measured	by	purified	protein	derivative–induced	
interferon-γ	release	in	ELISPOT	assays	of	peripheral	blood	
mononuclear cells. We found a positive correlation between 
strains with superior spreading capacity and their relative 
immunogenicity. Although our observation is true for M. tu-
berculosis and M. africanum strains, the association was 
especially	pronounced	in	1	M. africanum sublineage, char-
acterized	 by	 spoligotype	 shared	 international	 type	 181,	
which	is	responsible	for	20%	of	all	tuberculosis	cases	in	the	
region and therefore poses a major public health threat in 
The Gambia.
Tuberculosis (TB), caused by bacterial pathogens of the Mycobacterium tuberculosis complex (MTBC), is a 
major global health problem. Sub-Saharan Africa has the 
highest rate of TB per capita and the lowest case detec-
tion rate; although TB incidence is decreasing globally, in-
cidence rates are increasing in most countries in the West 
Africa region (1). Moreover, almost half of all TB cases in 
West Africa are caused by infection with an unusual mem-
ber of the MTBC, M. africanum, a lineage found exclu-
sively in this region. Although M. africanum was initially 
described in Senegal in 1968 (2), and despite its importance 
and high prevalence in this region, relatively little is known 
about the bacterium (3). In general, M. africanum can be 
divided into 2 lineages: Afri_1, by SpolDB4 definition (4), 
corresponding to the green lineage 6 (5), which has the 
highest prevalence in Senegal, Mali, The Gambia, Guinea-
Bissau, and Sierra Leone (3); and Afri_2 (4), correspond-
ing to the brown lineage 5 (5), which is mainly found in 
the eastern part of West Africa, in countries such as Côte 
d’Ivoire, Ghana, Benin, Nigeria, and Cameroon (3).
Although transmission of M. africanum from host to 
host is a crucial element of the spread of the disease, the 
underlying biological mechanisms triggering transmission 
are elusive. We assessed transmission dynamics and in-
teraction between the 2 mycobacterial populations in The 
Gambia, a country in western West Africa, and compared 
the local situation with previously published data from 
Guinea-Bissau, another country within the region (6). In 
particular, considering a recent publication suggesting that 
conserved mycobacterial T-cell epitopes may play a role 
in the transmission of the mycobacteria within the host 
population (7), we investigated whether differences in im-
munogenicity between M. tuberculosis and M. africanum 
strains (especially of the predominant Euro-American [EA] 
and Afri_1 lineages) could predict the success of certain 
sublineages to transmit and establish themselves within the 
human host population.
Materials and Methods
Study Population and Sample Collection
Data for our study came from an ongoing TB case–con-
tact study at the Medical Research Council in The Gambia; 
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TB case-patients were recruited for that study during June 
20, 2002–December 21, 2009. Consecutive patients were 
included after written informed consent if they were >15 
years old, resided in the study area (Greater Banjul area), 
and produced 2 sputum samples that were positive for acid-
fast bacilli by Ziehl-Neelsen staining.
Spoligotyping and Analysis
Genomic DNA was purified from the collected sputum 
samples by using the cetyl trimethyl ammonium bromide 
and chloroform method, as described (8). Spoligotyping 
was performed by using commercially available mem-
branes (Ocimum Biolsolutions, Hyderabad, India), ac-
cording to standardized protocols (9). Spoligotype patterns 
with ambiguous signature were confirmed by using long-
sequence polymorphism PCR.
In addition to analyzing the samples collected in The 
Gambia, we reanalyzed spoligotypes from published stud-
ies from Guinea-Bissau (6). The shared international type 
(SIT) number was assigned by using the SITVIT database 
on the Institute Pasteur de Guadeloupe website (www.pas-
teur-guadeloupe.fr/tb/bd_myco.html). Lineages of spoligo-
types were assigned according to SpolDB4 classification 
by using the TB Lineage online platform (http://tbinsight.
cs.rpi.edu/about_tb_lineage.html) (10). Spoligotype data 
were further analyzed by using spolTools (www.emi.unsw.
edu.au/spolTools) (11), which provides online tools for the 
construction of Spoligoforests (12) and to Detect Emerging 
Strains of Tuberculosis by Using Spoligotyping (DESTUS) 
(13) from spoligotype data. As recommended by the pro-
vider, the Spoligoforests and DESTUS programs were run 
with the default settings.
To analyze temporal clustering of spoligotypes from 
The Gambia, we used SaTScan version 9.1.1 software 
(www.satscan.org) (14); we conducted a purely temporal 
analysis for high rates of clustering in a discrete Poisson 
model. Hospital admission dates for each patient were used 
as input dates for each spoligotype, and the resolution of 
the analysis was set to days.
PPD-ELISPOT
Purified protein derivative (PPD) ELISPOT assays 
were performed as described (15) on a subset of 372 study 
samples. Quantitative results were expressed as the number 
of spot-forming units (sfu) that produce interferon-γ in re-
sponse to M. tuberculosis PPD antigen. Positive wells were 
predefined as containing >10 sfu more than, and at least 
2 times as many as, negative control wells. The negative 
control well was required to have <30 sfu.
Statistical Analysis
Odds ratios (ORs) and 95% CIs were calculated for 
analysis of cross-tabulations. To estimate differences 
between groups, the χ2 test was applied with 2-tailed p val-
ues. To confirm the results and to use a more accurate test 
for 2 × 2 tables, we also performed Fisher exact testing. We 
considered test results with p values <0.05 to be statisti-
cally significant.
The recent transmission index (RTI
n–1
) was calculat-
ed as described (16). Patients with singleton strains were 
considered to have TB from reactivation and not recent 
transmission and, therefore, RTI
n–1
 = 0. The average PPD 
response of patients with singleton strains was considered 
the baseline. Following calculation of the PPD response of 
the singleton strains, all recently transmitted strains with 
a cluster size of 2 were included, and the average PPD re-
sponse and RTI
n–1
 was re-calculated. This procedure was 
continued by stepwise inclusion of the next bigger geno-
typic cluster (i.e., [singleton] + [cluster n = 2] + [cluster n = 
3]; [singleton] + [cluster n = 2] + [cluster n = 3] + [cluster n 
= 4]; ...), and recalculation of the average PPD response for 
each respective RTI
n–1
 group was performed.
Results
Population Structure of MTBC and Transmission  
of Isolates
For the study period, 1,003 smear-positive TB cases 
were identified. Spoligotypes could be obtained from 884 
(88%) isolates; many of the strains collected belonged to 
the M. africanum Afri_1 or M. tuberculosis sensu stricto 
lineages, and 86% of all M. tuberculosis strains were part 
of the EA lineage. Therefore, for the remainder of the anal-
ysis, we compared all M. tuberculosis sensu stricto isolates 
(including EA), EA lineage isolates separately, and M. af-
ricanum Afri_1 isolates. For the 2 major lineages (Afri_1 
and EA), we identified 17–19 genotypes per 100 isolates, 
of which 9%–12% were found only once as singletons and 
thus were most likely the result of reactivation of previous 
disease (Table 1; Figure 1). The remaining spoligotypes 
(88%–91%) could be assigned to genotypic clusters with 
an average size of 11.8 and 13.3 isolates for M. tubercu-
losis EA and M. africanum Afri_1, respectively (Table 
1). Assuming that recent transmission was correlated with 
cluster size and that each cluster contained 1 index case, the 
RTI
n–1
 for both populations indicated that 80%–83% of TB 
cases were attributable to newly acquired infections.
Despite the similarities between the 2 mycobacterial 
populations, their individual compositions differed drasti-
cally. Whereas 59% of the M. africanum population was 
represented by only a single spoligotype, SIT 181, compris-
ing 198 isolates, the same proportion of the M. tuberculosis 
EA population contained as many as 11–12 smaller clusters 
of comparable sizes; with SIT 53 being the largest cluster 
(Figure 1). Consequently, the θ variable, a maximum-likeli-
hood estimate of the genetic diversity of a population (11), 
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was lower for M. africanum (θ = 22.7) than for M. tubercu-
losis EA (θ = 27.0) or for all M. tuberculosis sensu stricto 
(θ = 43.3). The effect of SIT 181 on the population structure 
became especially apparent when this cluster was exclud-
ed from the analysis, resulting in multiple changes to M. 
africanum population parameters, such as clustering rate, 
cluster size, and genetic diversity θ (Table 1). The drop in 
RTI also demonstrates the contribution of SIT 181 to recent 
transmission within the M. africanum Afri_1 lineage.
Spoligoforests of MTBC in West Africa
Using spoligoforests to display mycobacterial popula-
tions (12) takes the genetic relatedness of spoligotypes into 
consideration and allows deduction of relationships among 
bacterial sublineages. When we analyzed the 884 MTBC 
isolates from The Gambia, we found SIT 53 not only to be 
the most ancestral M. tuberculosis spoligotype but also to 
constitute the largest M. tuberculosis cluster (online Tech-
nical Appendix Figure, panel A, wwwnc.cdc.gov/EID/
article/19/10/12-1023-Techapp1.pdf). Besides this ances-
tral strain, we identified 4 more recent major spoligotype 
clusters (SITs 42, 47, 50, and 61) and 5 third-generation 
clusters (SITs 20, 60, 62, 144, and 183). Most strains be-
longed to the modern M. tuberculosis lineages. Moreover, 
when the distribution and size of these individual clusters 
was considered, M. tuberculosis strains seemed to spread 
evenly within the host population, resulting in a uniformly 
distributed structure of the bacterial population. In contrast, 
the M. africanum population was highly skewed toward a 
central cluster of SIT 181, next to which (with the excep-
tion of SIT 187) no notable secondary spoligotype clus-
ters emerged. Therefore, the population was concentrated 
around this spoligotype, and most cases of recently trans-
mitted disease could be attributed to this genotype. Similar 
results were found when we reanalyzed a published spoli-
gotype dataset from Guinea-Bissau (6), the West African 
country with the highest prevalence of M. africanum Afri_1 
strains (online Technical Appendix Figure, panel B).
DESTUS Analysis
As indicated by cluster size analysis and RTI
n–1
, SIT 
181 might be responsible for most recently transmitted TB 
cases in The Gambia. However, inferences about transmis-
sion that are purely based on cluster size analysis could be 
misleading because large clusters could equally be caused 
by an older strain that has been present for a long time or 
by strains that mutate slowly (13). To account for this im-
precision, the DESTUS model was developed to factor the 
 
Table	1.	Spoligotyping	results	for	comparative	population	structure	of	Mycobacterium tuberculosis sensu stricto (including EA), the EA 
clade separately, and M. africanum,	The	Gambia,	2002–2009* 
Parameters 
 
 
M. africanum 
Total 
M. tuberculosis sensu stricto Afri_1 
Afri_2 All lineages EA clade With	SIT	181 Without	SIT	181 
Population	parameters        
 No.	isolates	(n) 548 467  334 136 2 884 
 No.	genotypes 108 79  63 62 2 173 
 No.	singletons	(s) 60 43  41 41 2 103 
 No.	clusters	(c) 48 36  22 21 NA 70 
 Clustering rate, (n  s)/n 0.89 0.91  0.88 0.70 NA 0.88 
 Average cluster size, (n  s)/c 10.2 11.8  13.3 4.3 NA 11.2 
 Genetic diversity 40.0 27.0  22.7 43.4 NA 64.0 
Recent	transmission	index 0.80 0.83  0.81 0.54 NA 0.80 
*EA, Euro-American;	SIT,	shared	international	type;	NA,	not	applicable. 
 
Figure	1.	Spoligotyping	results	showing	population	structure	of	Mycobacterium tuberculosis and M. africanum,	The	Gambia,	2002–2009.	
A) All M. tuberculosis	sensu	stricto	lineages	(including	Euro-American);	B)	Euro-American	lineage;	C)	M. africanum	lineages	(Afri_1	and	
Afri_2).	SIT,	shared	international	type.
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mutation rates of spoligotypes into analysis of genotypic 
clustering as a measure of emerging strains (13). DESTUS 
testing of our dataset for the whole MTBC or stratified by 
M. tuberculosis versus M. africanum found that SIT 181 
was always detected as a highly significant emerging strain 
(p<10-30–10-31), followed by several other strains (Table 2). 
Similarly, SIT 181 was the only strain detected as emerging 
in the dataset from Guinea-Bissau (6).
Detecting Temporal Clusters of M. africanum SIT 181
To confirm previous results and to detect high rates of 
temporal clustering, we applied a purely temporal analysis 
to the M. africanum population by using the discrete Pois-
son model in SaTScan version 9.1.1 (www.satscan.org) 
(Table 3). We identified a significant (p = 0.001) temporal 
cluster of SIT 181 cases during August 2007–June 2008. 
This cluster showed an increased relative risk of 2.65 to the 
population for contracting SIT 181 when compared with 
the risk across the full study period (2002–2009).
Immunogenicity of MTBC Isolates
To identify associations between the emergence of cer-
tain genotypes and their immunogenicity, we used ELISPOT 
to measure PPD-induced interferon-γ responses in blood 
samples collected during 2002–2007 from patients infected 
with M. tuberculosis sensu stricto (n = 235), M. tuberculosis 
EA (n = 194), and M. africanum (n = 137). On the basis of 
the assumption that clustering is indicative of recent trans-
mission, we compared PPD ELISPOT positivity of clustered 
strains with singletons (Table 4). Our data suggest that M. af-
ricanum strains clustered by spoligotyping are significantly 
more likely to produce a positive PPD ELISPOT result than 
are singletons (OR 31.78, 95% CI 9.24–109.28; p = 0.0001). 
For M. tuberculosis sensu stricto and M. tuberculosis EA, we 
found a similar, yet not significant, tendency.
After applying more stringent criteria than mere clus-
tering, such as determining emerging strains (DESTUS), 
we compared PPD ELISPOT positivity of SIT 181 to sin-
gleton M. africanum Afri_1 strains; this analysis confirmed 
that SIT 181 is significantly more immunogenic than other 
types (OR 21.09, 95% CI 6.09–73.04; p = 0.0001). Simi-
larly, we found a slight, not significant tendency for pa-
tients infected with SIT 181 to be more likely than patients 
infected with singleton strains to yield a positive Mantoux 
skin test (OR 1.15, 95% CI 0.30–4.44).
Discussion
We found a correlation between MTBC strains of 
higher immunogenicity and their ability to spread within 
the human host population. In the study population in The 
Gambia, patients infected with strain SIT 181, the most 
prevalent M. africanum strain, were significantly more 
likely to yield a positive PPD ELISPOT result than were 
patients infected with M. africanum strains that do not have 
the ability to establish themselves within the human host 
population. To describe this association, we constructed a 
detailed population structure of MTBC isolates in which 
we analyzed 884 spoligotypes obtained from mycobacte-
rial isolates from TB cases identified during 2002–2009. 
We found that most circulating strains belonged to either 
the EA or M. africanum Afri_1 clades, and therefore, we 
specifically focused on the comparison between these 2 lin-
eages. On the basis of the assumption that clustered strains 
indicate recent transmission, we found that several M. tu-
berculosis strains appeared to have spread evenly within 
the host population. In contrast, most (59%) M. africanum 
transmission events and infections could be attributed to 
spoligotype SIT 181, which was responsible for 22% of all 
TB cases in the country. This result not only confirms re-
cent findings from Guinea-Bissau, in which SIT 181 caused 
up to 49% of all M. africanum infections (6), but is also in 
agreement with a previous study of a smaller set of isolates 
from this study that showed a similar strain distribution 
within the 2 major lineages (Afri_1 and EA) (17).
Although it is widely accepted that genetic clusters are 
indicative of recent transmission, caution must be taken with 
the interpretation of such findings because the successful 
spread of a strain within the population—and thus genetic 
clustering—is highly dependent on 2 properties of the bac-
teria. For successful spread, strains must transmit from in-
fected to uninfected host first; after this initial transmission, 
the infection must progress to active disease to be transmit-
ted to the next susceptible host. However, only case–con-
tact tracing studies, not molecular clustering data alone, can 
distinguish between transmission and progression of the 
 
Table	2.	Emerging	Mycobacterium tuberculosis complex strains 
as	detected	by	DESTUS	from	samples	collected	in	West	Africa* 
Study	site	and	years p value† 
Guinea	Bissau,	1989–2008  
 SIT	181	(Afri_1) 3.8	 10–8 
 SIT	187	(Afri_1) 4.7	 10–6 
The Gambia, 2002–2009  
 SIT	181	(Afri_1) 2.5	 10–30 
 SIT	187	(Afri_1) 5.1	 10–4 
 SIT	60	(M. tuberculosis) 1.5	 10–6 
 SIT	61	(M. tuberculosis) 2.9  10–4 
 SIT	183	(M. tuberculosis) 3.9	 10–4 
*Years	shown	indicate	when	samples	were	collected.	DESTUS,	Detect 
Emerging Strains of Tuberculosis by Using Spoligotyping (13);	SIT,	shared 
international	type;	Afri_1,	M. africanum West	Africa	2. 
†After	Sidak	Dunn	correction	for	type	I	error. 
 
 
 
Table	3.	Significant	temporal	clustering	of	human	cases	of	
infection with Mycobacterium africanum SIT	181,	The	Gambia,	
August	14,	2007–June	3,	2008* 
No.	cases 
Relative	risk LLR p value Actual Expected 
48 21.30 2.65 14.424230 0.001 
*Detected with SaTScan	version	9.1.1	software (www.satscan.org) (14) by 
applying	retrospective	purely	temporal	analysis	using	the	discrete	Poisson	
model.	SIT,	shared	international	type;	LLR,	log-likelihood ratio. 
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different lineages. Consequently, we refer here to the 
spreading capacity of strains, rather than to transmission.
Our analysis using DESTUS (13), which correctly pre-
dicted the widely accepted emergence of Beijing lineage M. 
tuberculosis strains in other studies (13), detected SIT 181 
as an unusually fast-growing strain relative to the myco-
bacterial background population of the sample. However, 
DESTUS does not take into account the migration history 
of Europeans and the mycobacteria they introduced into 
Africa. Because of this limitation, we sought to confirm 
our finding with a second approach and conducted a purely 
temporal analysis. We found that SIT 181 could have been 
emerging during a certain time in the study period, identi-
fying a temporal cluster during 2007–2008 for which risk 
for infection with SIT 181 was 2.65-fold higher than that 
for the whole study period (2002–2009).
With SIT 181 constituting such a prominent cluster, it 
is conceivable that the strain’s high prevalence is related 
to selective pressure through, for instance, antimicrobial 
drug therapy. However, because resistance rates are rela-
tively low in The Gambia (18), this explanation does not 
seem to apply. Therefore, we suggest another selective 
mechanism: we believe differences in spreading capac-
ity and the interaction between M. tuberculosis and M. 
africanum populations might play a crucial role. In con-
trast to M. africanum, several clustered strains within the 
M. tuberculosis population have comparable potential to 
spread within the human host population, but no strain has 
a notable advantage over another, which results in a well-
balanced population structure. We hypothesize that SIT 
181, in its expanded ability to spread, resembles these M. 
tuberculosis strains more than it does strains with other 
spoligotype patterns in the M. africanum lineage. Thus, 
SIT 181 has a selective advantage and is able to compete 
with M. tuberculosis for the same biological niche within 
the human host.
The nature and extent of epitope variation in M. tu-
berculosis strains is unclear. Findings range from highly 
variable T-cell epitopes within the esx gene family (19) to 
highly conserved epitopes when comparing genetic varia-
tion between predicted epitopes and the remainder of the 
M. tuberculosis genome (7). The latter study, which de-
scribed T-cell epitopes as highly conserved, suggests that 
hyperconservation of T-cell epitopes is beneficial for the 
bacteria and could result in the successful spread of strains. 
In our study, we sought to understand whether the magni-
tude of an induced immune response was correlated with 
the spreading capacity of the bacteria, with a special focus 
on SIT 181. We therefore investigated PPD ELISPOT re-
sponses of patients infected with either lineage and found 
a nonsignificant tendency for clustered M. tuberculosis 
sensu stricto and EA strains toward being more likely than 
singletons to produce a positive PPD result. This small dif-
ference in immunogenicity might be in line with our hy-
pothesis that the M. tuberculosis population spreads fairly 
homogenously. Consistent with the large observed differ-
ences in spreading capability, SIT 181 or clustered M. af-
ricanum strains have a 20- to 30-fold higher probability of 
yielding a positive PPD response (p<0.0001). This positive 
correlation between immunogenicity and spread becomes 
even more apparent when the RTI is plotted against the 
average quantitative PPD response (Figure 2). This com-
parison demonstrates not only the expected larger range in 
immunogenicity within the M. africanum lineage but also 
the phenotypic relatedness in immunogenicity of the highly 
spreading strains, independent of lineage.
An association between PPD response and spread-
ing capacity is conceivable. A previous publication found 
 
Table	4.	PPD	ELISPOT	results	for blood samples from patients infected with Mycobacterium tuberculosis sensu stricto (including EA 
lineage), M. tuberculosis EA lineage, and M. africanum strains, The Gambia, 2002–2007* 
Strain	and	result 
No.	spoligotypes 
Odds	ratio	(95%	CI) 
p value 
Clustered Singleton Total χ2 test† Fisher	exact	test‡ 
M. tuberculosis       
 Positive 182 19 201 1.65	(0.57–4.77) 0.3495 0.2533 
 Negative 29 5 34 0.61	(0.21–1.75) 0.3495 0.2533 
 Total 211 24 235    
M. tuberculosis EA       
 Positive 149 14 163 1.58	(0.48–5.15) 0.4479 0.3184 
 Negative 27 4 31 0.63	(0.19–2.07) 0.4479 0.3184 
 Total 176 18 194    
M. africanum       
 Positive 110 9 119 31.78	(9.24–109.28) 0.0001 0.0001 
 Negative 5 13 18 0.03	(0.01–0.11) 0.0001 0.0001 
 Total 115 22 137    
M. africanum SIT	181      
 Positive 73 9 82 21.09	(6.09–73.04) 0.0001 0.0001 
 Negative 5 13 18 0.05	(0.01–0.16) 0.0001 0.0001 
 Total 78 22 100    
*PPD,	purified	protein	derivative; EA, Euro-American. 
†2-tailed. 
‡1-tailed. 
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that household contacts who slept in the same bedroom as 
an index case-patient (i.e., who were exposed to the high-
est infectious loads) had higher PPD ELISPOT responses 
than did less-exposed household contacts (20). However, 
further analysis will be needed to conclusively address 
whether spreading capacity is determined by infectious 
load; smear-positivity grade of cases; magnitude of the in-
duced immune response; or an as-yet unknown immuno-
genic protein that enhances transmissibility, the absence of 
which (from strains of low spread) is merely reflected by a 
reduced ELISPOT response to PPD.
One possible limitation of spoligotype data is that the 
technique was designed on the basis of the clustered regu-
larly interspaced short palindromic repeats (CRISPR) re-
gions of M. tuberculosis sensu stricto and, therefore, could 
have a lower resolution when applied to M. africanum. 
Consequently, the large observed SIT 181 cluster could be 
a result of misclassification. Although the CRISPR regions 
of M. tuberculosis and M. africanum have not been exten-
sively compared, we believe misclassification is very un-
likely for 2 reasons. First, we found a comparable resolution 
of the technique for both lineages (18–19 genotypes/100 
isolates). Second, when calculating the Hunter-Gaston In-
dex (HGI), a measure for the discriminatory power of a 
technique, we found that HGI = 0.96 for spoligotyping of 
M. tuberculosis, HGI = 0.94 for M. africanum excluding 
SIT 181, and HGI = 0.64 for M. africanum with SIT181. 
Spoligotyping works equally well for 41% of M. africanum 
isolates and for M. tuberculosis isolates (0.94 vs. 0.96) but 
has drastically worse discriminatory power for the remain-
ing 59% of M. africanum strains (0.64). A drop in HGI that 
was a result of misclassification within the M. africanum 
lineage could only result from a CRISPR region or muta-
tion rate that was notably different between SIT 181 and 
the other M. africanum strains. However, this is unlikely 
because the remaining strains with HGI = 0.94 evolved out 
of SIT 181 and, thus, most likely have identical CRISPR 
regions and mutation rates. Therefore, by comparing these 
3 HGI results, we can conclude that SIT 181 is a real clus-
ter and not a result of misclassification. High-resolution 
genotyping methods, such as mycobacterial interspersed 
repetitive unit–variable number tandem repeat typing or 
whole-genome sequencing, is needed to conclusively con-
firm the genotypic homogeneity of the group of strains that 
constitute spoligotype pattern SIT 181.
We conclude that spoligotyping possesses compa-
rable discriminatory resolution for M. tuberculosis and 
M. africanum. We were able to demonstrate that SIT 181 
represents a strain (or family of strains) that clusters geno-
typically, temporally, and phenotypically and represents a 
major public health concern in West Africa, responsible for 
nearly one fourth of TB cases in The Gambia (22%) and 
Guinea-Bissau (23%) (6). Deciphering the virulence mech-
anisms that determine the differences in immunogenicity 
and spreading capacity between SIT 181 and the remaining 
singleton M. africanum strains will be key to improving TB 
prevention and transmission control in this region.
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Figure	 2.	 Linear	 regression	 analysis	
showing correlation between average 
quantitative	 purified	 protein	 derivative	
(PPD)	response	and	recent	transmission	
index	 (RTIn−1) for Mycobacterium 
tuberculosis complex isolates, The 
Gambia,	 2002–2007.	 Open	 diamonds	
and dashed line, M. tuberculosis sensu 
stricto, including Euro-American (EA) 
lineage	 (R2	 =	 0.606);	 open	 squares	
and dotted line, M. tuberculosis EA 
lineage	(R2	=	0.7272);	black	circles	and	
solid line, M. africanum Afri_1	 lineage	
(R2	=	0.7732).	sfu,	spot-forming	units.
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